Your browser doesn't support javascript.
loading
Intervention effectiveness by pharmacists integrated within an interdisciplinary health team on chronic complex patients.
Acosta-García, Hector; Alfaro-Lara, Eva Rocío; Sánchez-Fidalgo, Susana; Sevilla-Sánchez, Daniel; Delgado-Silveira, Eva; Juanes-Borrego, Ana; Santos-Ramos, Bernardo.
Afiliação
  • Acosta-García H; Pharmacy Service, University Hospital Virgen del Rocio, Seville, Spain.
  • Alfaro-Lara ER; Pharmacy Service, University Hospital Virgen del Rocio, Seville, Spain.
  • Sánchez-Fidalgo S; Department of Preventive Medicine and Public Health, University of Seville, Seville, Spain.
  • Sevilla-Sánchez D; Pharmacy Service, Vic Hospital Consortium, Central Catalonia Chronicity Research Group (C3RG), Vic, Spain.
  • Delgado-Silveira E; Pharmacy Service, University Hospital Ramón y Cajal, Madrid, Spain.
  • Juanes-Borrego A; Pharmacy Service, Hospital de la Santa Cre u Sant Pau, Barcelone, Spain.
  • Santos-Ramos B; Pharmacy Service, University Hospital Virgen del Rocio, Seville, Spain.
Eur J Public Health ; 30(5): 886-899, 2020 10 01.
Article em En | MEDLINE | ID: mdl-32052027
ABSTRACT

BACKGROUND:

Nowadays, it is difficult to establish a specific method of intervention by the pharmacist and its clinical repercussions. Our aim was to identify interventions by pharmacists integrated within an interdisciplinary team for chronic complex patients (CCPs) and determine which of them produce the best results.

METHODS:

A systematic review (SR) was performed based on PICO(d) question (2008-18) (Population) CCPs; (Intervention) carried out by health system pharmacists in collaboration with an interdisciplinary team; (Comparator) any; (Outcome) clinical and health resources usage outcomes; (Design) meta-analysis, SR and randomized clinical trials.

RESULTS:

Nine articles were included one SR and eight randomized clinical trials. The interventions consisted mainly in putting in order the pharmacotherapy and the review of the medication adequacy, medication reconciliation in transition of care and educational intervention for health professionals. Only one showed significant improvements in mortality (27.9% vs. 38.5%; HR = 1.49; P = 0.026), two in health-related quality of life [according to EQ-5D (European Quality of Life-5 Dimensions) and EQ-VAS (European Quality of Life-Visual Analog Scale) tests] and four in other health-related results (subjective self-assessment scales, falls or episodes of delirium and negative health outcomes associated with medication). Significant differences between groups were found in hospital stay and frequency of visits to the emergency department. No better results were observed in hospitalization rate. Otherwise, one study measured cost utility and found a cost of €45 987 per quality-adjusted life year gained due to the intervention.

CONCLUSIONS:

It was not possible to determine with certainty which interventions produce the best results in CCPs. The clinical heterogeneity of the studies and the short follow-up of most studies probably contributed to this uncertainty.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacêuticos / Qualidade de Vida Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacêuticos / Qualidade de Vida Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article